The white, round pill imprinted with “RP 10” is a highly regulated prescription medication containing Oxycodone Hydrochloride, 10 mg. Manufactured by Rhodes Pharmaceuticals, this immediate-release (IR) oral tablet is a potent opioid analgesic used for managing acute, severe pain. Because of its high potential for abuse, dependency, and severe respiratory side effects, it is classified as a Schedule II controlled substance in the United States.
Physical Identification
To minimize medication calculation errors or accidental ingestion, healthcare providers use specific physical traits to distinguish this medication:
- Imprint: “RP” is cleanly stamped on one side; the number “10” is stamped on the opposite side.
- Color: Solid White.
- Shape: Round.
- Form: Solid oral tablet (immediate-release formulation).
- Active Ingredient Strength: 10 mg of oxycodone hydrochloride per pill.
Mechanism of Action
Oxycodone is a semi-synthetic opioid derived from the poppy alkaloid thebaine. It functions primarily as a central nervous system (CNS) depressant tailored to alter the perception of pain.
Opioid Receptor Agonism
Oxycodone acts as a full agonist primarily at the mu-opioid receptors distributed throughout the brain, spinal cord, and smooth muscle tissues. It also displays a minor affinity for kappa and delta opioid receptors.
Cellular Cascade
When the “RP 10” pill dissolves and enters the systemic circulation, the oxycodone binds to these G-protein-coupled receptors. This binding initiates an intracellular cascade:
- It inhibits the adenylate cyclase enzyme.
- It closes voltage-gated calcium channels pre-synaptically, which halts the release of excitatory neurotransmitters (such as substance P, glutamate, and acetylcholine) responsible for transmitting pain signals.
- It opens potassium channels post-synaptically, hyperpolarizing the dorsal horn neurons of the spinal cord and preventing downstream pain signals from reaching the cerebral cortex. Ultimately, this does not eliminate the physical source of injury; rather, it profoundly alters the brain’s emotional and sensory response to pain, inducing analgesia and euphoria.
Approved Indications
The “RP 10” pill is strictly indicated for the management of acute, severe pain that is completely refractory to alternative treatments, such as non-opioid analgesics (e.g., ibuprofen, acetaminophen) or milder combination therapies. It is frequently prescribed for:
- Severe post-operative surgical pain.
- Acute trauma or severe bone fractures.
- Severe breakthrough pain in cancer or palliative care settings.
- This medication is not intended for mild pain, long-term chronic pain management (unless explicitly managed by a pain specialist), or as-needed (PRN) usage for minor discomfort.
Dosage and Administration
Dosage must be strictly individualized based on the patient’s opioid tolerance, body weight, age, and previous analgesic history.
Standard Clinical Dosing Range
- Opioid-Naive Adults: The typical starting dose is 2.5 mg to 5 mg taken every 4 to 6 hours as needed for severe pain. Therefore, a patient may begin by taking half of an “RP 10” tablet if scored, or progress to 1 whole tablet (10 mg) as tolerated and instructed by a doctor.
- Opioid-Tolerant Adults: Patients with prior opioid exposure may require 10 mg or higher maintenance doses, closely supervised by a clinician.
Crucial Safety Rules
- Do Not Crush or Modify: While the “RP 10” is an immediate-release tablet, it must be swallowed whole with water. Crushing, snorting, or dissolving the tablet completely bypasses normal metabolic pathways, leading to rapid, toxic systemic absorption and fatal overdose.
- Discontinuation: If taken for more than a few days, the medication should never be stopped abruptly. It requires a gradual tapering schedule to prevent severe physical withdrawal symptoms.
Side Effects
Like all potent opioids, oxycodone affects multiple biological systems, leading to a predictable profile of adverse effects.
Common Side Effects
- Gastrointestinal: Severe constipation (due to receptors slowing down intestinal motility), nausea, vomiting, and dry mouth.
- Neurological: Drowsiness, dizziness, sedation, headache, and a sense of intense euphoria or dysphoria.
- Dermatological: Pruritus (intense itching) and flushing caused by opioid-induced histamine release.
Severe Side Effects (Require Emergency Intervention)
- Respiratory Depression: Characterized by dangerously slow, shallow breathing, extreme lethargy, or blue-tinted lips/fingertips (cyanosis).
- Severe Hypotension: An acute drop in blood pressure, leading to fainting (syncope) or circulatory collapse.
- Serotonin Syndrome: Agitation, hallucinations, rapid heart rate, or muscle rigidity, especially when combined with antidepressant medications.
- Adrenal Insufficiency: Nausea, worsening weakness, or severe dizziness caused by chronic hormone suppression.
Warnings and Precautions
Boxed Risk: Addiction, Abuse, and Misuse
- Oxycodone exposes users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death. Assess a patient’s risk before prescribing, and monitor them regularly for the development of these behaviors or conditions.
Central Interactions & Warnings
- The Benzodiazepine/Alcohol Danger: Taking the “RP 10” pill alongside alcohol, benzodiazepines (e.g., Xanax, Valium), or other CNS depressants is a frequent cause of fatal overdoses. This combination exerts a synergistic depressive effect on the brainstem’s respiratory center, causing a total cessation of breathing.
- Neonatal Opioid Withdrawal Syndrome: Prolonged use of this medication during pregnancy can lead to life-threatening withdrawal symptoms in the newborn infant, requiring intensive care stabilization post-birth.
- Renal and Hepatic Impairment: The liver metabolizes oxycodone into noroxycodone and oxymorphone, while the kidneys excrete the metabolites. Patients with kidney or liver failure accumulate the drug rapidly and require lower doses to prevent overdose.
Overdose and Reversal Protocol
An overdose of the “RP 10” pill triggers the classic “Opioid Triad”:
- Pinpoint pupils (miosis).
- Severe respiratory depression (fewer than 8 to 10 breaths per minute).
- Unresponsiveness or deep coma.
If an overdose is suspected, Naloxone (Narcan) must be administered immediately via nasal spray or injection. Naloxone acts as a high-affinity competitive antagonist that physically displaces oxycodone from the opioid receptors, temporarily reversing respiratory depression. Because the half-life of oxycodone outlasts the duration of naloxone (~30 to 90 minutes), emergency medical personnel must still monitor the patient to ensure they do not slip back into a comatose state once the antidote wears off.